Rare diseases
Investigational molecules
Locations
Back to Germany85 clinical trials in Gauting, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
GermanyPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
GermanyStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
GermanyStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
GermanyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
GermanyStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
GermanyStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
GermanyAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
GermanyPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
GermanyA Study of ABBV-706 to Assess Safety and Efficacy Compared with Standard Drug Combination in Adults with Relapsed or Refractory Small Cell Lung Cancer
GermanyPumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation
GermanyA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including innovative combination therapies and targeted approaches for different disease stages.
Multiple studies evaluating novel drug combinations and immunotherapy approaches for improving patient outcomes.
Research focusing on small cell lung cancer (SCLC), particularly examining new treatment options for extensive-stage disease and therapy-resistant cases.
Investigations into innovative treatment combinations and maintenance therapies for better disease management.
Studies addressing various specialized lung conditions, including pleural mesothelioma and rare pulmonary diseases.
Clinical trials exploring targeted therapies and novel treatment approaches for rare and complex respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
